Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs Intravenous Tranexamic Acid in Total Hip Arthroplasty
NCT01940692Phase 2Completed
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Jul 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tranexamic acid (2 arms), sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Postoperative Blood Loss at Day 1. Started Jul 2014; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT01940692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01940692.